Interview with Germano Carganico, General Manager, Toscana Life Sciences
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Address: Via Fiorentina, 1 , 53100 Siena,Italy
Tel: +39 0577 231211
Web: http://www.toscanalifesciences.info/it/
Toscana Life Sciences (TLS) consists of both a Science park and a foundation.
TLS foundation is a non-profit organization founded in December 2004 by a group of public and private institutions in Tuscany, including the Province and Municipality of Siena, the Tuscany Region, the Monte Paschi Bank and Monte Paschi Foundation, the Chamber of Commerce of Siena, the Universities of Florence, Siena and Pisa, the Scuola Normale and Scuola St. Anna of Pisa, and the Hospital of Siena.
The Science Park represents the most important project of the TLS Foundation; its main aim is to offer equipped buildings, services and financing opportunities, thus creating a fertile ground for the development of new biotech companies focused on pharmaceutical, biotech, diagnostic and innovative biomedical technologies.
Besides the equipped labs and office rental, the TLS Science Park provides incubated companies with a full package of services, ranging from General Services, linked to day-to-day research activities, to Consultancy Services in line with company business management needs.
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Italy, Europe’s fourth largest pharma market at a size of EUR 23.446 billion, has a highly decentralised healthcare system, with the country’s 20 regions negotiating market access for medicines individually…
Pierre Fabre Italy’s Charles-Henri Bodin highlights how the French firm’s offering has expanded far beyond its dermo-cosmetics heritage to today encompass a wide range of pharmaceuticals, including the key growth…
Domenico Mantoan, General Manager of AGENAS, the Italian National Agency for Regional Health Services, discusses the role of the agency in Italy’s decentralised healthcare system, the National Recovery and Resilience…
Nicoletta Luppi, MSD Italia’s Senior Vice President & Managing Director details the need for healthcare reform in Italy and walks us through MSD’s portfolio priorities. In addition, she explains the…
In recent years, since the adoption of a law assuring its citizens’ right to access palliative care, Italy has given increased attention to pain management. According to Aldo Sterpone, Italy…
Aldo Sterpone, Grünenthal Italia’s General Manager, outlines the company’s focus on pain and its efforts to bring innovation to the area through R&D and acquisitions. He also explains the importance…
We spoke with Luca Crippa, CEO and Managing Director at IBSA Farmaceutici, about the company’s approach to developing new delivery technologies for existing and natural molecules, its focus on endocrinology,…
Stevanato Group’s CEO & COO, Franco Moro explaines how the over 70-year-old provider of containment and delivery solutions went public and as an established player in the vaccine space managed…
CAI is an engineering service company. Its regional manager for South Europe, Andrea Castiglioni, comments on the pharma industry’s need for commissioning and qualification services when looking to reduce time…
Merck Italia’s Managing Director & President, Jan Kirsten explains the importance of the Italian affiliate within the global organisation, Merck’s aim to strengthen its position in oncology and the challenges…
Over the past decade, the birth rate in Italy has consistently decreased, making it one of the countries with the lowest birth rates in the world but also one of…
Stanislao Caputo, GM at Aristo Pharma Italy, explains the Italian subsidiary’s strategy and how the diversification of its core business led to the acquisition of a portfolio of GSK dermo-cosmetic…
See our Cookie Privacy Policy Here
